Investment & M&A transaction comps

Vitamins Investment & M&A Transaction Comps

Explore investment and M&A transactions tagged vitamins. Compare companies, buyers, dates and available valuation multiples, with reported, estimated or rumored figures clearly labelled in each comp.

Coverage includes published FundComb transactions carrying this tag. Each comp preserves its own source notes and valuation basis.

Reviewed transactions
14
With value data
10
With revenue multiples
10
Transaction years
2012–2026

Sortable transaction comps

Vitamins transaction table

Filter transactions

Narrow the table without crowding the main view.

Clear all filters

Rows with reported value

10 / 14

Acquisition EV, USD

USD 18B

Investment EV, USD

-

Median EV / revenue

3.6x

Columns

Show columns

Select up to 12 rows across filters and pages, then share or export the set.

14 shown of 14 matching transactions. Click any transaction row for more detail.

Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.

Select for comparison
Thorne
Control
2026-08-04 Procter & Gamble 3,800 7.6x -
Vitabiotics
Control
2026-07-24 Bain Capital 1,038 - -
Sunday Natural
Control (55%)
2024-01-15 CVC Capital Partners 875 8.0x 16.0x
Blackmores
Control (100%)
2023-04-26 Kirin 1,241 2.9x 23.1x
2021-04-30 Nestlé 5,750 3.1x 16.8x
Smarty Pants
Control
2020-11-25 Unilever Undisclosed 4.0x -
Care/of
Control
2020-08-31 Bayer 225 - -
Nutranext
Control
2018-03-12 Clorox 700 3.5x 14.0x
2017-12-05 Nestlé 2,300 3.3x 19.0x
Vitaco
Control
2016-08-01 Primavera Capital Undisclosed 1.5x 14.7x
Swisse
Control (83%)
2015-09-17 Biostime 1,197 3.6x 10.2x
2012-11-22 Reckitt Benckiser Undisclosed 4.2x 19.1x
Twinlab
Control
- cbdMD Undisclosed - -
- Yellow Wood Partners 1,000 - -

Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.

Values may be estimated, rumored, incomplete or derived from public information. Transaction comps are informational and should not be relied on as financial, investment or valuation advice.